CHINA PHARMA HOLDINGS, INC. Increase (Decrease) in Prepaid Expenses, Other
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Increase (Decrease) in Prepaid Expenses, Other of $8.28 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpensesOther · last filed 2026-08-14
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2026-06-30 was $14.39K, a 557.80% increase year-over-year.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2026-03-31 was -$6.11K, a 125.80% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2025-12-31 was $5.80K.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2025-09-30 was -$32.45K.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in prepaid expenses, other for fiscal 2025 was -$793.00.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in prepaid expenses, other for fiscal 2024 was -$27.57K, a 209.87% decline from fiscal 2023.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in prepaid expenses, other for fiscal 2023 was $25.09K, a 1.48% increase from fiscal 2022.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in prepaid expenses, other for fiscal 2022 was $24.72K.
| Period end | Increase (Decrease) in Prepaid Expenses, Other 3 month | Increase (Decrease) in Prepaid Expenses, Other 3 month as first filed | Increase (Decrease) in Prepaid Expenses, Other 6 month | Increase (Decrease) in Prepaid Expenses, Other 6 month as first filed | Increase (Decrease) in Prepaid Expenses, Other 9 month | Increase (Decrease) in Prepaid Expenses, Other 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $8.28K 10-Q · filed 2026-08-14 | $14.08K derived: sum of 3 quarters · filed 2026-08-14 | -$18.37K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | -$6.11K 10-Q · filed 2026-05-15 | -$305.00 derived: sum of 2 quarters · filed 2026-05-15 | -$32.75K derived: sum of 3 quarters · filed 2026-05-15 | -$30.57K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | $5.80K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | -$26.65K derived: sum of 2 quarters · filed 2026-04-01 | -$24.46K derived: sum of 3 quarters · filed 2026-08-14 | -$793.00 10-K · filed 2026-04-01 | ||
| 2025-09-30 | -$32.45K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$30.26K derived: sum of 2 quarters · filed 2026-08-14 | -$6.59K 10-Q · filed 2025-11-12 | -$36.88K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | $2.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $25.85K 10-Q · filed 2026-08-14 | -$6.77K 10-Q · filed 2025-08-14 | -$4.43K derived: sum of 3 quarters · filed 2026-08-14 | -$7.76K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | $23.67K 10-Q · filed 2026-05-15 | $1.03K 10-Q · filed 2025-05-14 | -$6.62K derived: sum of 2 quarters · filed 2026-05-15 | -$9.95K derived: sum of 3 quarters · filed 2026-05-15 | -$97.73K derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | -$30.29K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | -$33.62K derived: sum of 2 quarters · filed 2026-04-01 | -$121.39K derived: sum of 3 quarters · filed 2026-04-01 | -$27.57K 10-K · filed 2026-04-01 | ||
| 2024-09-30 | -$3.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$91.11K derived: sum of 2 quarters · filed 2025-11-12 | $2.72K 10-Q · filed 2025-11-12 | -$169.86K derived: sum of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | -$87.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $6.05K 10-Q · filed 2025-08-14 | -$166.53K derived: sum of 3 quarters · filed 2025-08-14 | -$13.79K derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | $93.83K 10-Q · filed 2025-05-14 | -$78.75K derived: sum of 2 quarters · filed 2025-05-14 | $73.98K derived: sum of 3 quarters · filed 2025-05-14 | |||
| 2023-12-31 | -$172.58K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$19.85K derived: sum of 2 quarters · filed 2025-03-31 | $25.09K 10-K · filed 2025-03-31 | |||
| 2023-09-30 | $152.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $197.67K 10-Q · filed 2024-11-13 | ||||
| 2023-06-30 | $44.94K 10-Q · filed 2024-08-14 | |||||
| 2022-12-31 | -$12.32K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $24.72K 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | $37.05K 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |